Zoetis Opens Weak with 4.71% Gap Down Amid Market Concerns

Zoetis, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, opened today with a notable loss of 4.71%. This decline is part of a broader trend, as the stock has experienced a 4.94% decrease over the past day, significantly underperforming the S&P 500, which fell by 1.51%. Over the past month, Zoetis has seen a more substantial drop of 10.42%, compared to the S&P 500's decline of 5.83%. The company's market capitalization stands at approximately USD 53,244 million, categorizing it as a large-cap entity. Financial metrics reveal a price-to-earnings (P/E) ratio of 20.00 and a dividend yield of 1.71%. Additionally, Zoetis maintains a debt-to-equity ratio of 2.04, indicating a leveraged position, while its return on equity is notably high at 80.42%. Technical indicators present a mixed picture, with the MACD showing a mildly bullish trend on a weekly basis but bearish on a monthly scale. Moving averages and Bollinger Bands also reflect bearish sentiments, suggesting a cautious outlook in the short term.